Cargando…
Novel Immunotherapies for Osteosarcoma
Osteosarcoma (OS) is the most common primary malignant bone sarcoma mainly affecting adolescents and young adults, which often progresses to pulmonary metastasis and leads to the death of OS patients. OS is characterized as a highly heterogeneous cancer type and the underlying pathologic mechanisms...
Autores principales: | Lu, Yubao, Zhang, Jiahe, Chen, Yutong, Kang, Yuchen, Liao, Zhipeng, He, Yuanqi, Zhang, Cangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012135/ https://www.ncbi.nlm.nih.gov/pubmed/35433427 http://dx.doi.org/10.3389/fonc.2022.830546 |
Ejemplares similares
-
Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy
por: Luo, Zhong-Wei, et al.
Publicado: (2020) -
Case Report: Clinical application of immunotherapy-based combination regimen in primary osteosarcoma of the uterus
por: Yang, Jing, et al.
Publicado: (2023) -
Research Progress of MicroRNA in Chemotherapy Resistance of
Osteosarcoma
por: Tang, Zhaopeng, et al.
Publicado: (2021) -
Research Progress of Exosome-Loaded miRNA in Osteosarcoma
por: Yao, Peng, et al.
Publicado: (2022) -
Case Report: Primary osteosarcoma of the kidney
por: Chen, Junyong, et al.
Publicado: (2023)